Lesion-level PET/CT analysis to identify predictors of progression after BCMA CAR T-cell therapy in multiple myeloma

Fuente: PubMed "nature biotechnology"
Blood Cancer J. 2026 Aug 19;16(1):139. doi: 10.1038/s41408-026-01607-7.NO ABSTRACTPMID:42618556 | DOI:10.1038/s41408-026-01607-7
Volver